TAKARA HOLDINGS INC. reported revenue of ¥394.316 billion for the fiscal year ended March 2026, up 8.7%, while operating profit fell 17.1% to ¥17.076 billion. The overseas business performed strongly, but the bio business swung to a loss, weighing on results. Revenue and profit are expected to increase in the fiscal year ending March 2027 as a result of structural reforms.
According to TAKARA HOLDINGS INC.'s summary of earnings results for the fiscal year ended March 2026, revenue increased 8.7% year on year to ¥394.316 billion, while operating profit fell 17.1% to ¥17.076 billion. Revenue increased, but profit declined. The overseas business performed strongly, while the bio business swung to a loss, pushing down overall profit. This resulted in a pronounced decline in the operating profit margin.
According to announcements released the same day, revenue and profit are expected to increase in the fiscal year ending March 2027 through structural reforms, with a review of the business portfolio and cost improvements expected to progress.
Over the past 12 quarters, performance has been on a deteriorating trend. Net profit margin, operating profit margin and ROE/ROA have continued to decline, while profit growth has been sluggish relative to revenue growth.